Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07361952

Oral Versus Intravenous Fluid Therapy in the Emergency Department

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized clinical feasibility trial is to determine whether oral fluid therapy can achieve prescribed fluid volumes as effectively as intravenous fluid therapy in adult patients admitted to the emergency department who require fluid treatment. The main questions it aims to answer are: Are patients receiving oral fluids equally likely to achieve the prescribed fluid volume compared with patients receiving intravenous fluids? Is it feasible to conduct a randomized trial of oral versus intravenous fluid therapy in the emergency department, based on recruitment rate and protocol adherence? Researchers will compare oral tap water administration with standard intravenous crystalloid therapy to assess whether oral fluids are non-inferior in achieving prescribed fluid volumes and to evaluate feasibility outcomes. Participants will: Be randomized to receive either oral tap water or intravenous crystalloid fluids during their stay in the emergency department Receive a fluid volume and administration rate determined by the treating physician Be monitored according to standard clinical practice during the emergency department stay Have fluid intake, vital signs, and clinical outcomes recorded, with follow-up through routine health records up to 30 days after inclusion

Conditions

Interventions

TypeNameDescription
OTHEROral fluidsAny fluid volume prescribed by the physician during the ED stay is administered orally.
OTHERIntravenous fluidsAny fluid volume prescribed by the physician during the ED stay is administered intravenously.

Timeline

Start date
2025-10-03
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2026-01-23
Last updated
2026-01-23

Locations

3 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT07361952. Inclusion in this directory is not an endorsement.